Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Non-Resectable Adult Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Early research (Phase 1)Study completedNCT00093444
What this trial is testing

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Who this might be right for
Liver CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00073905
What this trial is testing

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Swiss Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT00083226
What this trial is testing

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Not applicableStudy completedNCT00482365
What this trial is testing

National Registry and Blood Bank of Patients With Liver Cancer

Who this might be right for
Liver Cancer
Vanderbilt-Ingram Cancer Center 151
Testing effectiveness (Phase 2)Ended earlyNCT01079767
What this trial is testing

Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 6
Early research (Phase 1)Ended earlyNCT00873002
What this trial is testing

Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT00003714
What this trial is testing

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01229111
What this trial is testing

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00777894
What this trial is testing

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Swiss Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00005629
What this trial is testing

Vaccine Therapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT01324076
What this trial is testing

Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University College, London 412
Testing effectiveness (Phase 2)UnknownNCT00003044
What this trial is testing

Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Matrix Pharmaceutical 55
Early research (Phase 1)Ended earlyNCT00003147
What this trial is testing

Gene Therapy in Treating Patients With Cancer of The Liver

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00006010
What this trial is testing

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Alliance for Clinical Trials in Oncology 25
Large-scale testing (Phase 3)Study completedNCT00003424
What this trial is testing

Tamoxifen in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
National Medical Research Council (NMRC), Singapore 300
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Next Page